Skip to main content

MoneyWorks4Me

Alembic Pharmaceuticals completes ANVISA GMP audit for API-II Facility in Panelav

11 Dec 2024 Evaluate

Alembic Pharmaceuticals has successfully completed the Brazilian Health Regulatory Agency (ANVISA) GMP audit at API-II Facilty at Panelav for its 8 APIs. The inspection was conducted from September 16, 2024 to September 20, 2024.

Alembic Pharmaceuticals is a vertically integrated research and development pharmaceutical company.


Peers
Company Name CMP
Sun Pharma. Inds. 1778.25
Dr. Reddys Labs. 1350.20
Cipla 1380.00
Lupin 2009.00
Zydus Lifesciences 1244.00
View more..